Jinbiao Zhan

MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis

David W. Chan, Mingo M. H. Yung, Yau-Sang Chan et al. · Pharmacological Research · 2020 · 125 citations · Full text

Medicine, Oncology, Pharmacology +14

Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes

Qingpo Li, Qin Tang, Peizun Zhang et al. · Biomaterials · 2015 · 58 citations

Medicine, Oncology, Pharmacology +12

RETRACTED: Bitter Melon ( <i>Momordica charantia</i> ) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

Mingo M. H. Yung, Fiona A. Ross, D. Grahame Hardie et al. · Integrative Cancer Therapies · 2015 · 46 citations · Full text

Medicine, Oncology, Pharmacology +16

A simplified method to evaluate the acute toxicity of ricin and ricinus agglutinin

Jinbiao Zhan, Zhou Peiheng · Toxicology · 2003 · 41 citations

Pharmacy, Biochemistry, Toxicology +5

A fusion protein of conotoxin MVIIA and thioredoxin expressed in Escherichia coli has significant analgesic activity

Jinbiao Zhan, Xiaoying Chen, Changmei Wang et al. · Biochemical and Biophysical Research Communications · 2003 · 31 citations

Life Sciences, Microbiology, Molecular Biology +13